Research into Alzheimer’s disease is shifting from amyloid plaque and tau protein to neuroinflammation, white matter changes...
Patrys Limited, a therapeutic antibody development company, has announced the publication of preclinical data for its therapeutic...
Sanofi and GSK started enrollment in their Phase 3 clinical study to assess the safety, efficacy, and immunogenicity of their adjuvanted recombinant-protein COVID-19...
A new report from University of Minnesota researchers shows that artificial heart valves implanted in lambs continued to grow and function for at least a year...
Patients in a Phase II trial have begun receiving Moderna’s vaccine against the SARS-CoV-2 variant first identified in South Africa, the company announced.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Researchers at Massachusetts General Hospital have developed a deep learning model that identifies imaging biomarkers on screening mammograms to predict a patient's...
A team from the Institut national de la recherche scientifique has demonstrated the effectiveness of an inexpensive molecule to fight antibiotic-resistant strains...
Researchers with Pfizer and IBM developed an artificial intelligence (AI) model that they claim can predict eventual onset of Alzheimer’s disease with 71% accuracy...
Selected for additional funding by Canadian Government bringing total support to $10M for clinical development and manufacturing of DPX-COVID-19